Metabolic syndrome and lower urinary tract symptoms: the role of inflammation. (Q45784694)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23165431%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

title

Metabolic syndrome and lower urinary tract symptoms: the role of inflammation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23165431%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23165431%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Cosimo De Nunzio

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23165431%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Linda Vignozzi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23165431%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

A Sebastianelli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23165431%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

M Salvi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23165431%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

C Giannessi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23165431%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

A Tubaro

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23165431%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

G Corona

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23165431%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

G Rastrelli

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23165431%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

R Santi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23165431%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

G Nesi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23165431%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

S Serni

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23165431%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

M Carini

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23165431%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

M Maggi

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23165431%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

publication date

20 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23165431%20AND%20SRC:MED&resulttype=core&format=json

Prostate Cancer and Prostatic Diseases

18 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23165431%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23165431%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23165431%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

page(s)

101-106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23165431%20AND%20SRC:MED&resulttype=core&format=json

Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.

18 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

Lower urinary tract symptoms, obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

Preclinical effects of melanocortins in male sexual dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

The correlation between metabolic syndrome and prostatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

Urinary symptoms, quality of life and sexual function in patients with benign prostatic hypertrophy before and after prostatectomy: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

A comparison of NCEP-ATPIII and IDF metabolic syndrome definitions with relation to metabolic syndrome-associated sexual dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

Inflammation and benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

High-intensity focused ultrasound: ready for primetime

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

Metabolic factors associated with benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

Central obesity as measured by waist circumference is predictive of severity of lower urinary tract symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

Chronic inflammation in the pathogenesis of benign prostatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

The functional role of reactive stroma in benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

Farnesoid X receptor activation improves erectile function in animal models of metabolic syndrome and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

Update on AUA guideline on the management of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy? PLESS Study Group. Proscar Long-Term Efficacy and Safety Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

Pathology of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

Standardized assessment to enhance the diagnostic value of prostate volume; Part I: Morphometry in patients with lower urinary tract symptoms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.44

31 March 2020

Identifiers

DOI

10.1038/PCAN.2012.44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23165431%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

18 February 2020

1032640414

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23165431%20AND%20SRC:MED&resulttype=core&format=json